On July 26, in the aftermath of the Democratic Party’s ruthless midsummer coup of its own democratically elected presidential nominee, this column predicted that the elevation of dimwitted cackler-in-chief Kamala Harris to the party’s presidential slot would “spectacularly backfire.” More specifically, I wrote:
Practically, the path to winning 270 Electoral College votes still runs through the Rust Belt states of Pennsylvania, Michigan and Wisconsin. It is frankly bizarre for Democrats to swap out the man who talks ceaselessly about his hardscrabble Scranton upbringing for a Californian who boasts the most left-wing voting record of any presidential nominee in modern history.
I’m feeling pretty good these days about that prognosis.
Harris recently campaigned in Erie, Pennsylvania—a crucial regional hub in this election cycle’s most important battleground state. Conspicuously absent from that snoozefest was incumbent Sen. Bob Casey Jr., D-Pa. Harris tried to pass off the snub as a nothingburger, suggesting that Casey was doing the more important work of knocking on doors and getting out the vote. This doesn’t pass the laugh test.
Facing a spirited challenge from Republican hopeful Dave McCormick, Casey has clearly concluded that Harris’ immense Bay Area lefty baggage—her history of endorsing the Green New Deal, a national fracking ban, and crippling electric vehicle mandates—is an electoral albatross around his neck.
It’s tough to blame Casey. Other vulnerable Senate Democratic incumbents, such as Sherrod Brown, D-Ohio, and Jon Tester, D-Mont., reached the same conclusion a while ago. Such a conclusion makes a great deal of sense: A recent Marist national general election poll, for instance, shows Donald Trump up a whopping 10 points on Harris with registered independents. If that margin ends up being anywhere near accurate, it is extraordinarily difficult to see a scenario in which Trump loses. […]
— Read More: www.dailysignal.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
